There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to ...

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

The primary difference is the dosing and FDA approval. Wegovy is FDA-approved for weight loss; the doses go up to 2.4mg.

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

The controlling shareholder in Novo Nordisk put in a request for EU approval for the deal on Oct. 31. The EU antitrust ...

Lisandra Silva says she faced complications after taking the drug for weight loss and found herself in the hospital as a ...

In today’s fast-paced world, weight management has become a significant concern for many individuals. With countless ...

Medically reviewed by Kristie Reed, PharmD Wegovy (semaglutide) is an injectable medication that is FDA-approved for obesity management and weight loss in people over age 12. Your healthcare provider ...